Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117128) titled 'A Prospective, Multicenter Study of Siltartoxatug Injection for the Prevention of Post-Traumatic Tetanus' on Jan. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Fuzhou University Affiliated Provincial Hospital
Condition:
Tetanus
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-23
Target Sample Size: Siltartoxatug Group:450;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=306049
Disclaimer: Curated by HT Syndication....